Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

Clinical trial NCT02028442 · COMPLETED

Trial details

NCT number: NCT02028442
Sponsor: Akamis Bio
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumours of Epithelial Origin Metastatic Colorectal Cancer Metastatic Bladder Cancer

Start date: 2012-09-20
Primary completion: 2016-04-29
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.